HUMA: Humacyte Inc

HUMA新闻

• Zacks 22:00 Humacyte, Inc. (HUMA) Stock Dips While Market Gains: Key Facts
• Zacks 22:15 Humacyte, Inc. (HUMA) Stock Falls Amid Market Uptick: What Investors Need to Know
• Benzinga 15:00 GE Vernova Posts Better-Than-Expected Earnings, Joins Thermo Fisher Scientific, Lennox International, General Dynamics And Other Big Stocks Moving Higher On Wednesday - Arrowhead Pharma (NASDAQ:ARWR), Abivax (NASDAQ:ABVX)
• Investing 13:12 Humacyte stock rises after first Symvess sale to US Military facility
• Zacks 22:00 Humacyte, Inc. (HUMA) Dips More Than Broader Market: What You Should Know
• Zacks 22:15 Why Humacyte, Inc. (HUMA) Dipped More Than Broader Market Today
• Benzinga 17:25 Gold Falls 1%; ProKidney Shares Spike Higher - Apogee Therapeutics (NASDAQ:APGE), Blue Gold (NASDAQ:BGL)
• Investing 15:26 Humacyte stock soars after Symvess gains DOD electronic catalog listing
• Investing 12:17 Humacyte’s Symvess gains DOD electronic catalog listing approval
• Investing 13:20 BTCC Exchange Reports Remarkable Q2 2025 Performance with $957 Billion Trading Volume
• Seeking Alpha 13:05 Humacyte: Revenue Ramp From Symvess Incoming (NASDAQ:HUMA)
• Investing 12:32 Results from Humacyte’s V007 Pivotal Phase 3 AV Access Study Highlighted by Presentation at the Society for Vascular Surgery Meeting
• Seeking Alpha 05:57 Humacyte Paradoxically Scales Back As Symvess Begins Its Long Journey (NASDAQ:HUMA)
• Investing 14:09 Humacyte Clinical Results in High-Risk Dialysis Patients from V007 Pivotal Phase 3
• Investing 18:04 Humacyte at H.C. Wainwright Conference: Promising Developments in SimVess
• Investing 20:32 Humacyte to Present at the H.C. Wainwright 3rd Annual BioConnect Investor Conference at Nasdaq
• Investing 14:37 Benchmark cuts Humacyte stock target to $14, maintains Buy rating
• Benzinga 20:56 Small-Caps Explode Higher As Tariff Fears Ease: Humacyte, Forward Air, FormFactor Top Russell 2000 - FormFactor (NASDAQ:FORM), FTAI Aviation (NASDAQ:FTAI)
• Seeking Alpha 17:48 Humacyte, Inc. (HUMA) Q4 2024 Earnings Conference Call Transcript
• Investing 15:07 Humacyte shares tumble 10% as Q4 loss narrows but revenue remains elusive
• Investing 21:59 Humacyte CEO addresses concerns in NYT over FDA approval of Symvess
• Seeking Alpha 20:28 Humacyte: Doubts Cast Around Efficacy Of Symvess May Be Hard To Dispel (NASDAQ:HUMA)
• Benzinga 14:47 Why Humacyte (HUMA) Stock Is Falling Sharply - Humacyte (NASDAQ:HUMA)
• Investing 11:57 Humacyte stock plunges on public offering pricing